Inhibiting transthyretin conformational changes that lead to amyloid fibril formation.
Peterson, S.A., Klabunde, T., Lashuel, H.A., Purkey, H., Sacchettini, J.C., Kelly, J.W.(1998) Proc Natl Acad Sci U S A 95: 12956-12960
- PubMed: 9789022 
- DOI: 10.1073/pnas.95.22.12956
- Primary Citation of Related Structures:  
1BM7, 1BMZ - PubMed Abstract: 
Insoluble protein fibrils resulting from the self-assembly of a conformational intermediate are implicated as the causative agent in several severe human amyloid diseases, including Alzheimer's disease, familial amyloid polyneuropathy, and senile systemic amyloidosis ...